CD200分子(CD200)活性蛋白
Active Cluster Of Differentiation 200 (CD200)
MOX1; MOX2; MRC; OX-2; My033; Antigen Identified By Monoclonal Antibody MRC OX-2
- 編號APA880Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點8.2
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 960 ¥ 2400 ¥ 4800 ¥ 14400 ¥ 36000
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實驗
Cluster Of Differentiation 200 (CD200), also known as OX-2 or MOX1/MOX2, is a membrane glycoprotein belonging to the immunoglobulin superfamily. This protein is widely expressed in various cell types, including neurons, endothelial cells, certain immune cells (such as B cells, dendritic cells, T cell subsets), and various tumor cells. CD200 is a multifaceted protein with important roles in immune regulation, neuronal function, and disease pathogenesis. Besides, Cluster Of Differentiation 8a (CD8a) has been identified as an interactor of CD200, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human CD200 and recombinant human CD8a. Briefly, CD200 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to CD8a-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-CD200 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630 nm immediately. The binding activity of recombinant recombinant human CD200 and recombinant human CD8a was shown in Figure 1, the EC50?for this effect is 0.44 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
EPA880Hu61 | CD200分子(CD200)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA880Hu01 | CD200分子(CD200)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA880Hu01 | CD200分子(CD200)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA880Hu01 | CD200分子(CD200)多克隆抗體 | WB; IHC |
FAA880Hu01 | 抗CD200分子(CD200)多克隆抗體 | Flow cytometry. |
FAA880Hu41 | 抗CD200分子(CD200)多克隆抗體(藻紅素標(biāo)記) | Flow cytometry. |
FAA880Hu51 | 抗CD200分子(CD200)多克隆抗體(別藻藍蛋白標(biāo)記) | Flow cytometry. |
FAA880Hu81 | 抗CD200分子(CD200)多克隆抗體(異硫氰酸熒光素標(biāo)記) | Flow cytometry. |
FAA880Hu31 | 抗CD200分子(CD200)多克隆抗體(別藻藍蛋白/花青染料cy7標(biāo)記) | FCM |
MAA880Hu23 | CD200分子(CD200)單克隆抗體 | WB; IHC; ICC; IP. |
MAA880Hu24 | CD200分子(CD200)單克隆抗體 | WB; IHC; ICC; IP. |
MAA880Hu22 | CD200分子(CD200)單克隆抗體 | WB; IHC; ICC; IP. |
RAA880Hu21 | CD200分子(CD200)重組抗體 | WB; IFC; IHC; IP; FCM |
FAA880Hu02 | 抗CD200分子(CD200)單克隆抗體 | FCM |
FAA880Hu04 | 抗CD200分子(CD200)單克隆抗體 | FCM |
FAA880Hu06 | 抗CD200分子(CD200)單克隆抗體 | FCM |
FAA880Hu08 | 抗CD200分子(CD200)單克隆抗體 | FCM |
SEA880Hu | CD200分子(CD200)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA880Hu | CD200分子(CD200)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Journal of Maternal-Fetal and Neonatal Medicine | Amniotic fluid CD200 levels in pregnancies complicated by preterm prelabor rupture of the membranes [PubMed: 23489112] |
Journal of Maternal-Fetal and Neonatal Medicine | Amniotic fluid CD200 levels in pregnancies complicated by preterm prelabor rupture of the membranes. [Pubmed: 23489112] |
Medicine | Pre-transplant CD200 and CD200R1 concentrations are associated with post-transplant events in kidney transplant recipients [Pubmed: 31517819] |
Molecular Biology Reports | Umbilical cord-derived mesenchymal stem cell conditioned medium reverses neuronal oxidative injury by inhibition of TRPM2 activation and the JNK signaling?… [Pubmed:35585377] |